Intrinsic Value of S&P & Nasdaq Contact Us

Certara, Inc. CERT NASDAQ

NASDAQ Global Select • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
47/100
2/7 Pass
SharesGrow Intrinsic Value
$17.33
+197.8%
Analyst Price Target
$10.00
+71.8%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Certara, Inc. (CERT) has a negative trailing P/E of -532.6, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 12.9 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -0.19%, forward earnings yield 7.74%. PEG 0.95 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (60/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.95); analyst target implies upside (+71.8%).
  • Forward P/E 12.9 — analysts expect a return to profitability with estimated EPS of $0.45 for FY2026.
  • PEG Ratio 0.95 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -0.19% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 7.74% as earnings recover.
  • Analyst consensus target $10.00 (+71.8% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 47/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
47/100
SG Score
View full scorecard →
VALUE
60/100
Price-to-Earnings & upside
Proven by this page
FUTURE
64/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
60/100
→ Income
~
GROWTH
40/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — CERT

Valuation Multiples
P/E (TTM)-532.6
Forward P/E12.9
PEG Ratio0.95
Forward PEG0.95
P/B Ratio0.80
P/S Ratio2.01
EV/EBITDA5.9
Per Share Data
EPS (TTM)$-0.01
Forward EPS (Est.)$0.45
Book Value / Share$6.63
Revenue / Share$2.61
FCF / Share$0.56
Yields & Fair Value
Earnings Yield-0.19%
Forward Earnings Yield7.74%
Dividend Yield0.00%
SharesGrow IV$17.33 (+197.8%)
Analyst Target$10.00 (+71.8%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2018 -151.6 0.00 10.23 30.80 -
2019 -671.2 8.68 12.18 28.73 -
2020 -104.4 -0.22 6.27 21.18 -
2021 -321.0 4.44 4.09 14.88 -
2022 171.1 -0.83 2.34 7.51 -
2023 -50.5 0.11 2.67 7.89 -
2024 -141.7 1.80 1.61 4.44 -
2025 -885.9 10.22 1.33 3.37 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2018 $-0.25 $163.72M $-33.26M -20.3%
2019 $-0.06 $208.51M $-8.93M -4.3%
2020 $-0.32 $243.53M $-49.4M -20.3%
2021 $-0.09 $286.1M $-13.27M -4.6%
2022 $0.09 $335.64M $14.73M 4.4%
2023 $-0.35 $354.34M $-55.36M -15.6%
2024 $-0.08 $385.15M $-12.05M -3.1%
2025 $-0.01 $418.84M $-1.6M -0.4%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.45 $0.43 – $0.46 $427.88M $427.25M – $429.26M 6
2027 $0.50 $0.48 – $0.53 $450.74M $439.29M – $465.29M 6
2028 $0.57 $0.16 – $0.97 $490.81M $488.31M – $493.32M 2
2029 $0.66 $0.65 – $0.68 $501.7M $493.74M – $512.9M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message